These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 1082902
1. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens. Treves AJ, Schechter B, Cohen IR, Feldman M. J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902 [Abstract] [Full Text] [Related]
2. Macrophage-mediated in vitro sensitization of lymphocytes. II. The detection of neo-antigens on transformed lymphocytes and passages of normal fibroblasts. Treves AJ, Declève A, Lieberman M, Feldman M, Kaplan HS. J Immunol; 1978 Jun; 120(6):1947-51. PubMed ID: 659886 [Abstract] [Full Text] [Related]
3. In vitro sensitization of human lymphocytes against allogeneic cells by antigen-fed macrophages. Treves AJ, Heidelberger E, Feldman M, Kaplan HS. Isr J Med Sci; 1979 Jul; 15(7):564-9. PubMed ID: 478818 [Abstract] [Full Text] [Related]
4. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens. Burton RC, Chism SE, Warner NL. J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394 [Abstract] [Full Text] [Related]
5. Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine. Schechter B, Segal S, Feldman M. J Immunol; 1978 Apr; 120(4):1268-73. PubMed ID: 641348 [Abstract] [Full Text] [Related]
6. Sequential interaction of macrophages, initiator T lymphocytes and recruited T lymphocytes in a cell-mediated immune response to soluble antigen. Steinman L, Tzehoval E, Cohen IR, Segal S, Glickman E. Eur J Immunol; 1978 Jan; 8(1):29-34. PubMed ID: 76565 [Abstract] [Full Text] [Related]
7. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Fidler IJ, Bucana C. Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034 [Abstract] [Full Text] [Related]
8. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. Fujii T, Igarashi T, Kishimoto S. J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265 [Abstract] [Full Text] [Related]
9. Destruction of experimental malignant melanoma by mediators of cellular immunity. Youdim S. Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681 [Abstract] [Full Text] [Related]
10. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages. Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T. J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520 [Abstract] [Full Text] [Related]
11. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process. Igarashi T, Okada M, Kishimoto T, Yamamura Y. J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145 [Abstract] [Full Text] [Related]
12. Co-operation between macrophages and a factor from lymphocytes in tumor lysis in vitro. Yamazaki M, Shinoda H, Mizuno D. Gan; 1975 Oct; 66(5):489-97. PubMed ID: 1082827 [Abstract] [Full Text] [Related]
13. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens. Eggers AE, Wunderlich JR. J Immunol; 1975 May; 114(5):1554-6. PubMed ID: 123545 [Abstract] [Full Text] [Related]
14. The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells. Fujiwara H, Takai Y, Sakamoto K, Hamaoka T. J Immunol; 1985 Sep; 135(3):2187-91. PubMed ID: 3874911 [Abstract] [Full Text] [Related]
15. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages. Mitani M, Matsumoto T, Mori K, Miake S, Himeno K, Nomoto K. J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795 [Abstract] [Full Text] [Related]
16. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. Yoshida R, Yoneda Y, Kuriyama M, Kubota T. J Immunol; 1999 Jul 01; 163(1):148-54. PubMed ID: 10384111 [Abstract] [Full Text] [Related]
17. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. Ting CC, Rodrigues D. J Natl Cancer Inst; 1982 Oct 01; 69(4):867-72. PubMed ID: 6214653 [Abstract] [Full Text] [Related]
18. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay. Raina S, Russo AJ, Jenkins D, Goldrosen MH. Cancer Res; 1981 Oct 01; 41(10):3950-5. PubMed ID: 6456811 [Abstract] [Full Text] [Related]
19. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages. Jones B, Jones TC. Immunology; 1978 Feb 01; 34(2):247-55. PubMed ID: 414994 [Abstract] [Full Text] [Related]
20. Macrophage cytotoxicity factor. A product of in vitro sensitized thymus-dependent cells. Lohmann-Matthes ML, Ziegler FG, Fischer H. Eur J Immunol; 1973 Jan 01; 3(1):56-8. PubMed ID: 4197970 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]